EdgeRock Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Buy
+464
New +$276K 0.07% 112
2026
Q1
– Sell
-375
Closed -$217K – 138
2025
Q4
$217K Buy
+375
New +$212K 0.06% 122
2022
Q4
– Sell
-92
Closed -$47K – 360
2022
Q3
$47K Buy
+92
New +$51.5K 0.03% 108

Other funds holding TMO

EdgeRock Capital's TMO Position: Q3 2026 in Review

EdgeRock Capital opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 464 shares worth $313K. The stake represents 0.07% of the portfolio and ranks #112 among its holdings. This is a return to the name: EdgeRock Capital previously reported a position in TMO as recently as Q4 2025.

EdgeRock Capital first reported a position in TMO in Q3 2022 and has held it in 3 quarters since. 1,740 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • EdgeRock Capital held 464 shares of Thermo Fisher Scientific worth $313K as of Q3 2026.
  • Thermo Fisher Scientific was a new EdgeRock Capital position in Q3 2026.
  • Thermo Fisher Scientific made up 0.07% of EdgeRock Capital's portfolio in Q3 2026, its #112 holding.
  • EdgeRock Capital first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 3 quarters since.
  • 1,740 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on EdgeRock Capital's 13F filing for Q3 2026, filed 3 Nov 2026.